Table A4.3 Cost-effectiveness results for the ideal scenario and for scenario 2 when RT was compared to no treatment.

Average cost per patientAverage survival per patientAverage time ambulant per patientAverage QALYs per patientICER: ∆ Cost per QALY
Ideal scenario
RT alone939011.5711.570.67Dominant
No treatment4867311.570.000.10
Scenario 2
RT alone305237.131.900.153309
No treatment302087.130.000.06

From: Appendix 4, An economic evaluation of treatments for people with suspected metastatic spinal cord compression

Cover of Metastatic Spinal Cord Compression
Metastatic Spinal Cord Compression: Diagnosis and Management of Patients at Risk of or with Metastatic Spinal Cord Compression.
NICE Clinical Guidelines, No. 75.
National Collaborating Centre for Cancer (UK).
Copyright © 2008, National Collaborating Centre for Cancer.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licenses issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.